Australia Legal Cannabis Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025–2030

Australia legal cannabis market, valued at USD 860 million, grows due to legalization for medical purposes, rising patient demand, and expansion in cultivation facilities.

Region:Asia

Author(s):Geetanshi

Product Code:KRAE1976

Pages:94

Published On:February 2026

About the Report

Base Year 2024

Australia Legal Cannabis Market Overview

  • The Australia Legal Cannabis Market is valued at USD 860 million, based on a five-year historical analysis. This growth is primarily driven by increasing acceptance of cannabis for medical use, coupled with a growing consumer base for recreational products. The market has seen a surge in demand due to changing regulations and a shift in public perception towards cannabis, leading to a more robust legal framework.
  • Key players in this market include major cities such as Sydney, Melbourne, and Brisbane, which dominate due to their large populations and progressive attitudes towards cannabis legalization. These urban centers have become hubs for cannabis cultivation and distribution, supported by local governments that promote cannabis-related businesses and research initiatives.
  • The Narcotic Drugs Act 1967, administered by the Office of Drug Control within the Australian Government Department of Health and Aged Care, governs the licensing for cultivation and production of cannabis for medicinal purposes. This binding instrument requires applicants to meet strict security, facility, and Good Manufacturing Practice standards, with licences specifying approved quantities, active ingredients, and export thresholds to ensure supply chain integrity and patient safety.
Australia Legal Cannabis Market Size

Australia Legal Cannabis Market Segmentation

By Source:The market is segmented into two primary sources: Hemp and Marijuana. Hemp is increasingly favored for its versatility in various products, including textiles and food, while Marijuana is primarily sought after for its psychoactive and therapeutic properties. The demand for both sources is driven by consumer preferences and the expanding range of applications in health and wellness.

Australia Legal Cannabis Market segmentation by Source.

By Derivatives:This segmentation includes CBD, THC, and Others. CBD products are gaining traction due to their therapeutic benefits without the psychoactive effects, while THC remains popular for recreational use. The 'Others' category encompasses various cannabis-infused products, reflecting the growing innovation in the market.

Australia Legal Cannabis Market segmentation by Derivatives.

Australia Legal Cannabis Market Competitive Landscape

The Australia Legal Cannabis Market is characterized by a dynamic mix of regional and international players. Leading participants such as Cann Group Limited, AusCann Group Holdings Ltd, Zelira Therapeutics, Bod Australia, Althea Group Holdings Limited, THC Global Group Limited, MGC Pharmaceuticals Ltd, Ecofibre Limited, Little Green Pharma, Botanix Pharmaceuticals, Incannex, Epsilon, Medlab Clinical Ltd, Creso Pharma Limited, Harvest One Cannabis Inc. contribute to innovation, geographic expansion, and service delivery in this space.

Cann Group Limited

2014

Melbourne, Australia

AusCann Group Holdings Ltd

2017

Perth, Australia

Zelira Therapeutics

2016

Perth, Australia

Bod Australia

2014

Sydney, Australia

Althea Group Holdings Limited

2017

Sydney, Australia

Company

Establishment Year

Headquarters

Year-over-Year Revenue Growth Rate (%)

Market Share (%)

Product Portfolio Breadth (Number of SKUs)

Geographic Presence (Number of States/Territories)

Cultivation Capacity (kg/annum)

Regulatory Compliance Status (TGA Approval Rate)

Australia Legal Cannabis Market Industry Analysis

Growth Drivers

  • Increasing Legalization and Acceptance:The Australian legal cannabis market is experiencing significant growth due to the increasing legalization of cannabis for medicinal use. As of future, over 120,000 patients are registered for medicinal cannabis prescriptions, reflecting a 20% increase from previous year. This shift is supported by the Australian government’s commitment to expanding access, with the Therapeutic Goods Administration (TGA) approving more products, thus enhancing public acceptance and driving market growth.
  • Rising Demand for Medicinal Cannabis Products:The demand for medicinal cannabis products in Australia is projected to reach AUD 1.8 billion by future, driven by an increasing number of patients seeking alternative treatments for chronic pain, anxiety, and other conditions. The Australian Institute of Health and Welfare reported that 1 in 4 Australians suffer from chronic pain, creating a substantial market for effective medicinal cannabis solutions. This growing patient base is a key driver of market expansion.
  • Expansion of Cannabis Cultivation and Production Facilities:The number of licensed cannabis cultivation facilities in Australia has surged to over 300 as of future, a 50% increase from the previous year. This expansion is fueled by favorable government policies and investments in infrastructure, allowing for increased production capacity. The Australian government’s investment of AUD 60 million in agricultural technology is expected to enhance cultivation efficiency, further supporting market growth and product availability.

Market Challenges

  • Regulatory Hurdles and Compliance Issues:The legal cannabis market in Australia faces significant regulatory hurdles, with compliance costs estimated at AUD 1.2 million per facility annually. These costs arise from stringent licensing requirements and ongoing regulatory changes, which can deter new entrants and stifle innovation. The complexity of navigating these regulations poses a challenge for existing businesses, impacting their operational efficiency and profitability.
  • Stigma and Misinformation Surrounding Cannabis Use:Despite increasing acceptance, stigma and misinformation about cannabis use persist in Australia. A recent survey indicated that 35% of Australians still hold negative views about cannabis, which can hinder market growth. This societal perception affects consumer willingness to engage with cannabis products, creating barriers to market penetration and limiting the potential customer base for legal cannabis businesses.

Australia Legal Cannabis Market Future Outlook

The future of the Australian legal cannabis market appears promising, driven by ongoing legislative reforms and increasing consumer acceptance. As more states consider legalization and the medical community recognizes cannabis's therapeutic benefits, the market is expected to see a surge in product innovation. Additionally, advancements in cultivation technology and sustainable practices will likely enhance production efficiency, positioning Australia as a competitive player in the global cannabis market landscape.

Market Opportunities

  • Development of Innovative Cannabis Products:There is a significant opportunity for the development of innovative cannabis products, particularly in the wellness and beauty sectors. The global wellness market is projected to reach AUD 5 trillion by future, and incorporating cannabis into these products can attract health-conscious consumers, driving sales and market growth.
  • Partnerships with Healthcare Providers:Establishing partnerships with healthcare providers presents a lucrative opportunity for cannabis companies. Collaborations can facilitate better patient education and access to cannabis treatments, potentially increasing prescription rates. With over 85% of Australian doctors open to discussing cannabis as a treatment option, these partnerships can significantly enhance market penetration and consumer trust.

Scope of the Report

SegmentSub-Segments
By Source

Hemp

Marijuana

By Derivatives

CBD

THC

Others

By Cultivation Method

Indoor Cultivation

Greenhouse Cultivation

Outdoor Cultivation

By End-Use

Medical Use

Recreational Use

Industrial Use

By Geographic Region

Australia Capital Territory & New South Wales

Victoria & Tasmania

Queensland

Western Australia

Northern Territory & Southern Australia

Key Target Audience

Investors and Venture Capitalist Firms

Government and Regulatory Bodies (e.g., Australian Therapeutic Goods Administration, Office of Drug Control)

Manufacturers and Producers

Distributors and Retailers

Pharmaceutical Companies

Healthcare Providers

Industry Associations (e.g., Cannabis Industry Association of Australia)

Financial Institutions

Players Mentioned in the Report:

Cann Group Limited

AusCann Group Holdings Ltd

Zelira Therapeutics

Bod Australia

Althea Group Holdings Limited

THC Global Group Limited

MGC Pharmaceuticals Ltd

Ecofibre Limited

Little Green Pharma

Botanix Pharmaceuticals

Incannex

Epsilon

Medlab Clinical Ltd

Creso Pharma Limited

Harvest One Cannabis Inc.

Table of Contents

Market Assessment Phase

1. Executive Summary and Approach


2. Australia Legal Cannabis Market Overview

2.1 Key Insights and Strategic Recommendations

2.2 Australia Legal Cannabis Market Overview

2.3 Definition and Scope

2.4 Evolution of Market Ecosystem

2.5 Timeline of Key Regulatory Milestones

2.6 Value Chain & Stakeholder Mapping

2.7 Business Cycle Analysis

2.8 Policy & Incentive Landscape


3. Australia Legal Cannabis Market Analysis

3.1 Growth Drivers

3.1.1 Increasing legalization and acceptance of cannabis
3.1.2 Rising demand for medicinal cannabis products
3.1.3 Expansion of cannabis cultivation and production facilities
3.1.4 Growing consumer awareness and education

3.2 Market Challenges

3.2.1 Regulatory hurdles and compliance issues
3.2.2 Stigma and misinformation surrounding cannabis use
3.2.3 Competition from illegal markets
3.2.4 Limited access to banking and financial services

3.3 Market Opportunities

3.3.1 Development of innovative cannabis products
3.3.2 Export opportunities to international markets
3.3.3 Partnerships with healthcare providers
3.3.4 Investment in research and development

3.4 Market Trends

3.4.1 Increasing focus on sustainability in cannabis production
3.4.2 Rise of cannabis-infused beverages and edibles
3.4.3 Growth of online cannabis retail platforms
3.4.4 Emergence of personalized cannabis products

3.5 Government Regulation

3.5.1 Legalization of medicinal cannabis use
3.5.2 Licensing requirements for producers and retailers
3.5.3 Advertising and marketing restrictions
3.5.4 Taxation policies on cannabis sales

4. SWOT Analysis


5. Stakeholder Analysis


6. Porter's Five Forces Analysis


7. Australia Legal Cannabis Market Market Size, 2019-2024

7.1 By Value

7.2 By Volume

7.3 By Average Selling Price


8. Australia Legal Cannabis Market Segmentation

8.1 By Source

8.1.1 Hemp
8.1.2 Marijuana

8.2 By Derivatives

8.2.1 CBD
8.2.2 THC
8.2.3 Others

8.3 By Cultivation Method

8.3.1 Indoor Cultivation
8.3.2 Greenhouse Cultivation
8.3.3 Outdoor Cultivation

8.4 By End-Use

8.4.1 Medical Use
8.4.2 Recreational Use
8.4.3 Industrial Use

8.5 By Geographic Region

8.5.1 Australia Capital Territory & New South Wales
8.5.2 Victoria & Tasmania
8.5.3 Queensland
8.5.4 Western Australia
8.5.5 Northern Territory & Southern Australia

9. Australia Legal Cannabis Market Competitive Analysis

9.1 Market Share of Key Players

9.2 Cross Comparison of Key Players

9.2.1 Company Name
9.2.2 Year-over-Year Revenue Growth Rate (%)
9.2.3 Market Share (%)
9.2.4 Product Portfolio Breadth (Number of SKUs)
9.2.5 Geographic Presence (Number of States/Territories)
9.2.6 Cultivation Capacity (kg/annum)
9.2.7 Regulatory Compliance Status (TGA Approval Rate)
9.2.8 Distribution Channel Diversity Index
9.2.9 R&D Investment as % of Revenue
9.2.10 Customer Acquisition Cost (CAC)

9.3 SWOT Analysis of Top Players

9.4 Pricing Analysis

9.5 Detailed Profile of Major Companies

9.5.1 Cann Group Limited
9.5.2 AusCann Group Holdings Ltd
9.5.3 Zelira Therapeutics
9.5.4 Bod Australia
9.5.5 Althea Group Holdings Limited
9.5.6 THC Global Group Limited
9.5.7 MGC Pharmaceuticals Ltd
9.5.8 Ecofibre Limited
9.5.9 Little Green Pharma
9.5.10 Botanix Pharmaceuticals
9.5.11 Incannex
9.5.12 Epsilon
9.5.13 Medlab Clinical Ltd
9.5.14 Creso Pharma Limited
9.5.15 Harvest One Cannabis Inc.

10. Australia Legal Cannabis Market End-User Analysis

10.1 Procurement Behavior of Key Ministries

10.1.1 Government Procurement Policies
10.1.2 Budget Allocations for Cannabis Programs
10.1.3 Collaboration with Private Sector
10.1.4 Others

10.2 Corporate Spend on Infrastructure & Energy

10.2.1 Investment in Cannabis Facilities
10.2.2 Energy Consumption Patterns
10.2.3 Infrastructure Development Needs
10.2.4 Others

10.3 Pain Point Analysis by End-User Category

10.3.1 Access to Quality Products
10.3.2 Pricing Concerns
10.3.3 Regulatory Compliance Issues
10.3.4 Others

10.4 User Readiness for Adoption

10.4.1 Awareness Levels
10.4.2 Perceived Benefits
10.4.3 Barriers to Adoption
10.4.4 Others

10.5 Post-Deployment ROI and Use Case Expansion

10.5.1 Measurement of ROI
10.5.2 Expansion into New Use Cases
10.5.3 Long-term Benefits Analysis
10.5.4 Others

11. Australia Legal Cannabis Market Future Size, 2025-2030

11.1 By Value

11.2 By Volume

11.3 By Average Selling Price


Go-To-Market Strategy Phase

1. Whitespace Analysis + Business Model Canvas

1.1 Market Gaps Identification

1.2 Business Model Development


2. Marketing and Positioning Recommendations

2.1 Branding Strategies

2.2 Product USPs


3. Distribution Plan

3.1 Urban Retail Strategies

3.2 Rural NGO Tie-ups


4. Channel & Pricing Gaps

4.1 Underserved Routes

4.2 Pricing Bands


5. Unmet Demand & Latent Needs

5.1 Category Gaps

5.2 Consumer Segments


6. Customer Relationship

6.1 Loyalty Programs

6.2 After-sales Service


7. Value Proposition

7.1 Sustainability

7.2 Integrated Supply Chains


8. Key Activities

8.1 Regulatory Compliance

8.2 Branding

8.3 Distribution Setup


9. Entry Strategy Evaluation

9.1 Domestic Market Entry Strategy

9.1.1 Product Mix
9.1.2 Pricing Band
9.1.3 Packaging

9.2 Export Entry Strategy

9.2.1 Target Countries
9.2.2 Compliance Roadmap

10. Entry Mode Assessment

10.1 Joint Ventures

10.2 Greenfield Investments

10.3 Mergers & Acquisitions

10.4 Distributor Model


11. Capital and Timeline Estimation

11.1 Capital Requirements

11.2 Timelines


12. Control vs Risk Trade-Off

12.1 Ownership vs Partnerships


13. Profitability Outlook

13.1 Breakeven Analysis

13.2 Long-term Sustainability


14. Potential Partner List

14.1 Distributors

14.2 Joint Ventures

14.3 Acquisition Targets


15. Execution Roadmap

15.1 Phased Plan for Market Entry

15.1.1 Market Setup
15.1.2 Market Entry
15.1.3 Growth Acceleration
15.1.4 Scale & Stabilize

15.2 Key Activities and Milestones

15.2.1 Milestone Planning
15.2.2 Activity Tracking

Research Methodology

ApproachModellingSample

Phase 1: Approach1

Desk Research

  • Analysis of government publications and reports on cannabis legalization and regulation in Australia
  • Review of market reports from industry associations and research firms focusing on the legal cannabis sector
  • Examination of academic journals and articles discussing the economic impact of cannabis legalization

Primary Research

  • Interviews with key stakeholders including cannabis cultivators, distributors, and retailers
  • Surveys targeting consumers to understand purchasing behavior and preferences in the legal cannabis market
  • Focus groups with healthcare professionals to gauge perceptions of cannabis use for medicinal purposes

Validation & Triangulation

  • Cross-validation of findings through comparison with international cannabis market trends
  • Triangulation of data from regulatory bodies, market participants, and consumer insights
  • Sanity checks conducted through expert panel discussions with industry veterans and analysts

Phase 2: Market Size Estimation1

Top-down Assessment

  • Estimation of total addressable market based on national cannabis consumption statistics and demographic data
  • Segmentation of the market by product type (recreational vs. medicinal) and distribution channel (online vs. retail)
  • Incorporation of projected growth rates based on legislative changes and consumer acceptance

Bottom-up Modeling

  • Collection of sales data from leading cannabis dispensaries and producers to establish baseline revenue figures
  • Analysis of production costs and pricing strategies employed by cannabis growers
  • Volume estimates based on cultivation capacity and projected market demand

Forecasting & Scenario Analysis

  • Development of forecasting models incorporating variables such as changing regulations and market entry of new players
  • Scenario analysis based on potential shifts in public perception and health studies related to cannabis use
  • Creation of multiple growth scenarios (conservative, moderate, aggressive) through 2030

Phase 3: CATI Sample Composition1

Scope Item/SegmentSample SizeTarget Respondent Profiles
Recreational Cannabis Consumers150Adult Consumers, Cannabis Enthusiasts
Medical Cannabis Patients100Patients with Prescriptions, Healthcare Providers
Cannabis Retailers80Store Managers, Owners of Dispensaries
Cultivators and Producers70Farm Owners, Production Managers
Regulatory Bodies and Policy Makers50Government Officials, Legal Advisors

Frequently Asked Questions

What is the current value of the Australia Legal Cannabis Market?

The Australia Legal Cannabis Market is valued at approximately USD 860 million, reflecting significant growth driven by increasing acceptance of cannabis for medical use and a rising consumer base for recreational products.

What are the main drivers of growth in the Australia Legal Cannabis Market?

Which cities are leading in the Australia Legal Cannabis Market?

What regulations govern the cultivation of cannabis in Australia?

Why Buy From Us?

Refine Robust Result (RRR) Framework
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follow Robust, Refine and Result (RRR) methodology. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents' facts and opinions, and Result for presenting data with story.

Our Reach Is Unmatched
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Shifting the Research Paradigm
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

More Insights-Better Decisions
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Transparency and Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

Round the Clock Support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Clients Choose Us?

400000+
Reports in repository
150+
Consulting projects a year
100+
Analysts
8000+
Client Queries in 2022